InvestorsHub Logo
Followers 8
Posts 1379
Boards Moderated 0
Alias Born 03/27/2013

Re: None

Monday, 07/15/2013 2:29:33 PM

Monday, July 15, 2013 2:29:33 PM

Post# of 425931
FDA - Incompetence or Fraudulence? It is beyond comprehension that the FDA has failed again to act on the NCE decision for Vascepa. The damage that has befallen our investment in Amarin over the last year is incalculable and much of that lies at the FDA doorstep! Although I acknowledge that it is likely to be futile, it is my fervent wish that BioBill really does have some completely unexpected surprise connection with the Feds. The perpetrators of this fraud at the FDA truly deserve to be dragged through the dirt. They are despicable human beings!
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News